Afrezza (MNKD) - Sof marja

Afrezza (MNKD) grafik logotipi

MannKind Corporation Afrezza ning innovatsion o'pka orqali yetkazib berish tizimi yordamida endokrinologiya bozoridagi o'z mavqeini kengaytirmoqda. Foyda marjasi ushbu strategiyaning samaradorligini tasdiqlaydi, bunda -18.10 ko'rsatkichning joriy qiymatini aks ettiradi. Shifokorlar orasidagi yuqori brend obro'si bemorlarning ishonchini ta'minlaydi. Ixtisoslashgan tadqiqotchilardan iborat barqaror shtat va tijorat ekspertlarini maqsadli ishga olish biznesning barqaror o'sishini kafolatlaydi.

Afrezza (MNKD) Sotuvning sof marjinal rentabelligi: 04.07.2022 - 20.11.2026 davri uchun

MannKind Corp. (MNKD) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi ko'rsatkichlari:
Kompaniyaning jamlanma tahlili:MannKind, MNKD
MannKind Corp ishlab chiqargan mahsulot

MannKind Corporation (MNKD) uchun, uning daromadlari Afrezza va Tyvaso DPI royalti to'lovlarining tijoratlashtirilishiga bog'liq bo'lib, sof foyda marjasi innovatsiyalarni monetizatsiya qilish samaradorligini aks ettiradi. Ushbu ko'rsatkich har bir dollar daromadning yakuniy foydadagi ulushini o'lchaydi, bu esa investorga joriy rentabellikning tarixiy qiymatlardan og'ishini baholash va biznes hayot siklining bosqichini aniqlash imkonini beradi.

MannKind Corporation kimlar bilan raqobatlashadi

HLN: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi KVUE|Sof marja veronapharma.com|Sotuvning sof rentabelligi MENS (Jyong Biotech Corp)|Sof marja Ligand (LGND)|Sotuvning sof marjinal rentabelligi amneal.com (AMRX)|Sotuvning sof marjinal rentabelligi PRGO (perrigo.com)|Alvotech SA (ALVO) - Sof marja|Liquidia Inc. - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Sof marja|amphastar.com (AMPH) - Sotuvning sof marjinal rentabelligi|PCRX (Pacira Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi ARS Pharmaceuticals, Inc. (SPRY)|Sotuvning sof marjinal rentabelligi TBPH|AQST (Aquestive Therapeutics) - Sof foyda normasi|scPharmaceuticals, Inc. - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi TECX|tonixpharma.com - Sotuvning sof marjinal rentabelligi|Sof foyda normasi SXTC (sxtchina.com)|Eupraxia Pharma (EPRX) - Sof marja|Sof foyda bo'yicha sotuv rentabelligi BioHarvest|Sof foyda bo'yicha sotuv rentabelligi EXOZ|Sof foyda bo'yicha sotuv rentabelligi Oramed Pharmaceuticals (ORMP)|Sof foyda bo'yicha sotuv rentabelligi ENTX (Entera Bio Corp)|MindWalk Holdings Inc. - Sotuvning sof rentabelligi|Sotuvning sof marjinal rentabelligi ABVC (ABVC BioPharma Inc)|CPIX - Sof foyda bo'yicha sotuv rentabelligi|Quantum BioPharma Corp - Sotuvning sof marjinal rentabelligi|FGEN (fibrogen.com) - Sotuvning sof rentabelligi|TELO (Telomir Pharmaceuticals) - Sof foyda bo'yicha sotuv rentabelligi|Rani Therapeutics Holdings - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi SNYR|Sof marja rallybio.com RLYB|Sotuvning sof marjinal rentabelligi LEXX|PULM (Pulmatrix, Inc.) - Sof foyda normasi|Pheton Holdings - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Aptorum Group Limited APM|LYRA: Sof foyda bo'yicha sotuv rentabelligi|IBO: Sof marja|TNFA: Sotuvning sof marjinal rentabelligi|YCBD: Kompaniyaning sof rentabelligi|Sof marja PainReform Ltd|CYTO (altamiratherapeutics.com) - Kompaniyaning sof rentabelligi|Sotuvning sof marjinal rentabelligi LIPO|OPTN - Sof marja|Sof marja pieris.com PIRS|Sof foyda normasi PROC|PTPI - Sof marja|Qilian International Holding (QLI) - Sof foyda bo'yicha sotuv rentabelligi|SLRN: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi TFF Pharma